Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors:: Initial experience in 26 patients

被引:104
作者
Kettenbach, J
Köstler, W
Rücklinger, E
Gustorff, B
Hüpfl, M
Wolf, F
Peer, K
Weigner, M
Lammer, J
Müller, W
Goldberg, SN
机构
[1] Univ Vienna, Sch Med, Dept Diagnost Radiol, Div Angiog & Intervent Radiol, A-1090 Vienna, Austria
[2] Stat Anal Method Consulting, A-1200 Vienna, Austria
[3] Univ Vienna, Dept Anesthesiol & Intens Care B, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Radiotherapy, A-1090 Vienna, Austria
[5] Wilhelminenspital Stadt Wien, A-1160 Vienna, Austria
[6] Univ Dept Biomed Engn, Fachhsch Furtwangen, D-78054 Villingen Schwenningen, Germany
[7] Beth Israel Deaconess Med Ctr, Dept Radiol, Harvard Med Sch, Boston, MA 02215 USA
关键词
D O I
10.2214/ajr.180.6.1801537
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. The purpose of our study was to evaluate the safety and efficacy of percutaneous saline-enhanced radiofrequency ablation for unresectable primary or metastatic hepatic tumors. Subjects and Methods. Twenty-six patients with 15 hepatocellular carcinomas and 33 hepatic metastases (maximum diameter less than or equal to8.6 cm) were treated; of these, seven tumors in five patients were treated twice. Thus, 44 radiofrequency treatments were performed. Saline-enhanced and impedance-controlled radiofrequency ablation (0.5-1.1 mL/min of saline, 15-mm conductive portion of the electrode tip, 25-60 W, 5-43 min) was performed using MR imaging guidance. Coagulation necrosis, volume indexes, morbidity, and complications were assessed. Results. The volume of coagulation necrosis 1-7 days after radiofrequency ablation was 1.6-126.6 cm(3) (median, 18.9 cm(3)), corresponding to coagulation diameters of 1.5-6.2 cm (median, 3.2 cm). The coagulation volume was significantly larger if there were more than four radiofrequency applications (p=0.006). Tumors of 3 cm or less in diameter were eight times as likely to be successfully completely ablated (p=0.01) and volume indexes of lesions treated with the patient under general anesthesia were significantly larger than those treated with the patient under conscious sedation (p<0.001). Major complications occurred in four patients (15%). Incomplete ablation in 19 (35%) of 54 radiofrequency lesions was due to cooling by a large vessel nearby (n=2) or to low power applied in painful (n=11) or critical (n=6) locations. Residual tumor was observed in 14 (58%) of 24 tumors evaluated 6-8 months after radiofrequency ablation. Conclusion. Percutaneous saline-enhanced and impedance-controlled radiofrequency ablation can be effective in the treatment of unresectable hepatic tumors and minimizes potential carbonization. A greater number of radiofrequency applications, general anesthesia, and increasing experience provide significantly better results.
引用
收藏
页码:1537 / 1545
页数:9
相关论文
共 36 条
[1]   Radio-frequency tumor ablation: Internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model [J].
Boehm, T ;
Malich, A ;
Goldberg, SN ;
Reichenbach, JR ;
Hilger, I ;
Hauff, P ;
Reinhardt, M ;
Fleck, M ;
Kaiser, WA .
RADIOLOGY, 2002, 222 (03) :805-813
[2]   Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors [J].
Bowles, BJ ;
Machi, J ;
Limm, WML ;
Severino, R ;
Oishi, AJ ;
Furumoto, NL ;
Wong, LL ;
Oishi, RH .
ARCHIVES OF SURGERY, 2001, 136 (08) :864-868
[3]   Liver lesions: Manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization - Comparison with receiver operating characteristic analysis [J].
Braga, HJV ;
Choti, MA ;
Lee, VS ;
Paulson, EK ;
Siegelman, ES ;
Bluemke, DA .
RADIOLOGY, 2002, 223 (02) :525-531
[4]   Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum [J].
Burdío, F ;
Güemes, A ;
Burdío, JM ;
Castiella, T ;
De Gregorio, MA ;
Lozano, R ;
Livraghi, T .
ACADEMIC RADIOLOGY, 1999, 6 (11) :680-686
[5]  
*CANC THER EV PROG, COMM TOX CRIT
[6]   Radio-frequency ablation of liver tumors: Assessment of therapeutic response and complications [J].
Choi, H ;
Loyer, EM ;
DuBrow, RA ;
Kaur, H ;
David, CL ;
Huang, S ;
Curley, S ;
Charnsangavej, C .
RADIOGRAPHICS, 2001, 21 :S41-S54
[7]   Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies - Results in 123 patients [J].
Curley, SA ;
Izzo, F ;
Delrio, P ;
Ellis, LM ;
Granchi, J ;
Vallone, P ;
Fiore, F ;
Pignata, S ;
Daniele, B ;
Cremona, F .
ANNALS OF SURGERY, 1999, 230 (01) :1-8
[8]   Radiofrequency liver ablation: Experimental comparative study of water-cooled versus expandable systems [J].
de Baere, T ;
Denys, A ;
Wood, BJ ;
Lassau, N ;
Kardache, M ;
Vilgrain, V ;
Menu, Y ;
Roche, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (01) :187-192
[9]   Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion [J].
de Baere, T ;
Bessoud, B ;
Dromainm, C ;
Ducreux, M ;
Boige, V ;
Lassau, N ;
Smayra, T ;
Girish, BV ;
Roche, A ;
Elias, D .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (01) :53-59
[10]   Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations [J].
Dodd, GD ;
Frank, MS ;
Aribandi, M ;
Chopra, S ;
Chintapalli, KN .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 177 (04) :777-782